Inside a One-Man Workshop for Ultrapotent Drugs

Last fall, a man who calls himself Chemical Analyst allowed two New York Times reporters to watch on a secure video call as he packaged ultrapotent synthetic drugs for distribution. These chemicals now flood the modern drug market. Many have psychoactive effects that are much more intense than those of traditional drugs. One newly emerging…

Read More

The Fast-Changing Chemistry of New, Dangerous Drugs

Illicit labs are creating new synthetic drugs at breakneck speed. Dangerous, untested compounds are reaching users long before health agencies know they exist. Older drugs are regularly modified to create novel threats. Ecstasy is a prime example. The party drug MDMA has been illegal since 1985. Its molecular structure can be drawn like this: But…

Read More

12 Hours in the Smoke

Across the country, wildfire fighters work for weeks at a time in poisonous smoke. Across the country, wildfire fighters work for weeks at a time in poisonous smoke. The government says they are protected. The government says they are protected. We tested the air at one fire to find out why they are still dying….

Read More

Read the MAHA strategy report

ADVANCE RESEARCH Vaccine Injury HHS, in collaboration with NIH, will investigate vaccine injuries with improved data collection and analysis, including through a new vaccine injury research program at the NIH Clinical Center that may expand to centers around the country. Water Quality The EPA and USDA, along with other…

Read More

Democrats Grill N.I.H. Leader on Cuts: Who Is Calling the Shots?

As the Trump administration clamped down on the country’s medical research funding apparatus in recent months, scientists and administrators at the National Institutes of Health often privately wondered how much autonomy the agency’s director, Dr. Jay Bhattacharya, had. After all, the Department of Government Efficiency, Elon Musk’s signature cost-cutting project, helped drive decisions to cancel…

Read More